JPS5229320B1 - - Google Patents

Info

Publication number
JPS5229320B1
JPS5229320B1 JP46087235A JP8723571A JPS5229320B1 JP S5229320 B1 JPS5229320 B1 JP S5229320B1 JP 46087235 A JP46087235 A JP 46087235A JP 8723571 A JP8723571 A JP 8723571A JP S5229320 B1 JPS5229320 B1 JP S5229320B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP46087235A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5229320B1 publication Critical patent/JPS5229320B1/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP46087235A 1970-11-03 1971-11-04 Pending JPS5229320B1 (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT31308/70A IT1043823B (it) 1970-11-03 1970-11-03 Procedimento per l estrazione di acidi nucleici da organi animali

Publications (1)

Publication Number Publication Date
JPS5229320B1 true JPS5229320B1 (OSRAM) 1977-08-01

Family

ID=11233430

Family Applications (1)

Application Number Title Priority Date Filing Date
JP46087235A Pending JPS5229320B1 (OSRAM) 1970-11-03 1971-11-04

Country Status (7)

Country Link
US (1) US3770720A (OSRAM)
JP (1) JPS5229320B1 (OSRAM)
DE (2) DE2154277A1 (OSRAM)
FR (2) FR2131249A5 (OSRAM)
GB (2) GB1367656A (OSRAM)
IT (1) IT1043823B (OSRAM)
SE (2) SE385902B (OSRAM)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5967214A (ja) * 1982-10-12 1984-04-16 Kazuo Suga 化粧品組成物
EP0107161B1 (de) * 1982-10-26 1989-08-09 CTA Finanz AG Mittel und Verfahren zur Optimierung der Gewebemasse von Organen innerhalb der genetischen Schwankungsbreite bei Menschen und Tieren
IT1170214B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per la cura delle arteriopatie periferiche
IT1170215B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta
IT1206341B (it) * 1984-02-16 1989-04-14 Crinos Industria Farmaco Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
IT1187833B (it) * 1985-12-12 1987-12-23 Farmigea Spa Procedimento per l ottenimento di polidesossiribonucleotidi non informazionali sostanzialmente puri e dotati di attivita biologiche e prodotto relativo
IT1190313B (it) * 1986-04-17 1988-02-16 Crinos Industria Farmaco Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
IT1212143B (it) 1987-06-26 1989-11-08 Crinos Industria Farmaco Composizione ad attivita'tricogena.
IT1222701B (it) * 1987-09-23 1990-09-12 Crinos Industria Farmaco Composizione ad uso topico avente attivita' tricogena,antiforfora ed antiseborroica
IT1223322B (it) * 1987-10-23 1990-09-19 Crinos Industria Farmaco Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
IT1231509B (it) * 1989-09-07 1991-12-07 Crinos Industria Farmaco Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
US5977083A (en) * 1991-08-21 1999-11-02 Burcoglu; Arsinur Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
US6699985B2 (en) * 1991-08-21 2004-03-02 Arsinur Burcoglu Method of treating HIV infection and related secondary infections thereof
IT1252174B (it) * 1991-12-09 1995-06-05 Crinos Industria Farmaco Oligodesossimibonucleotidi ad attivita' antiischemica e procedimenti per il loro ottenimento
US7683035B1 (en) 1999-02-23 2010-03-23 Qiagen, Gmbh Method of stabilizing and/or isolating nucleic acids
EP1059092B1 (en) 1999-06-08 2005-12-07 Gentium S.p.A. Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments
US6323743B1 (en) * 1999-08-24 2001-11-27 Tresness Irrevocable Patent Trust Electronic filter assembly
US8771663B2 (en) * 2000-04-18 2014-07-08 Gentium Spa Formulation having mobilising activity
EP1147777A1 (en) 2000-04-18 2001-10-24 Crinos Industria Farmacobiologica S.p.A. Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors
ITMI20031714A1 (it) * 2003-09-05 2005-03-06 Gentium Spa Formazioni ad azione antitumorale.
MX2007010754A (es) * 2005-03-03 2007-11-07 Gentium Spa Defibrotide y/u oligodeoxiribonucleotidos para tratar tumores dependientes de angiogenesis.
EP1872787A1 (en) * 2006-06-27 2008-01-02 Gentium S.p.A. Use of defibrotide for the inhibition of heparanase
EP1982722A1 (en) * 2007-04-16 2008-10-22 Gentium S.p.A. Use of oligotide for the treatment of renal diseases
EP2103689A1 (en) * 2008-03-19 2009-09-23 Gentium S.p.A. Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
CN107007617A (zh) 2010-11-12 2017-08-04 真蒂奥姆责任有限公司 去纤维蛋白多核苷酸用于预防和/或治疗移植物抗宿主病(gvhd)
CA2874960C (en) 2012-06-22 2021-05-18 Gentium S.P.A. Euglobulin-based method for determining the biological activity of defibrotide
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
EP3661484A1 (en) 2017-08-03 2020-06-10 Jazz Pharmaceuticals Ireland Limited Formulations comprising a nucleic acid in a high concentration
WO2019200251A1 (en) 2018-04-12 2019-10-17 Jazz Pharmaceuticals, Inc. Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
US20220023533A1 (en) 2018-12-07 2022-01-27 Jazz Phrmaceticals Ireland Limited Subcutaneous delivery of high concentration formulations
EP4110287A1 (en) 2020-02-28 2023-01-04 Jazz Pharmaceuticals Ireland Limited Delivery of low viscosity formulations
US20230086833A1 (en) 2020-04-17 2023-03-23 Jazz Pharmaceuticals Ireland Limited Defibrotide treatment for the prevention of organ rejection and injury
WO2022234101A1 (en) 2021-05-06 2022-11-10 Jazz Pharmaceuticals Ireland Limited Defibrotide for the treatment and prevention of acute respiratory distress syndrome

Also Published As

Publication number Publication date
DE2154277A1 (de) 1972-05-25
FR2131249A5 (OSRAM) 1972-11-10
DE2154278A1 (de) 1972-05-25
SE385376B (sv) 1976-06-28
DE2154277C2 (OSRAM) 1988-04-07
GB1366647A (en) 1974-09-11
SE385902B (sv) 1976-07-26
IT1043823B (it) 1980-02-29
GB1367656A (en) 1974-09-18
US3770720A (en) 1973-11-06
FR2131248A5 (OSRAM) 1972-11-10

Similar Documents

Publication Publication Date Title
FR2131248A5 (OSRAM)
AU1473870A (OSRAM)
AU1146470A (OSRAM)
AU2044470A (OSRAM)
AU2017870A (OSRAM)
AU1517670A (OSRAM)
AU2085370A (OSRAM)
AU1833270A (OSRAM)
AU1336970A (OSRAM)
AU1326870A (OSRAM)
AU2130570A (OSRAM)
AU2112570A (OSRAM)
AU2144270A (OSRAM)
AU1189670A (OSRAM)
AU1974970A (OSRAM)
AU1277070A (OSRAM)
AU1841070A (OSRAM)
AU1872870A (OSRAM)
AU1879170A (OSRAM)
AU1881070A (OSRAM)
AU1918570A (OSRAM)
AU1943370A (OSRAM)
AU1343870A (OSRAM)
AU1969370A (OSRAM)
AU2131570A (OSRAM)